Agenus Inc. (AGEN)
NASDAQ: AGEN · Real-Time Price · USD
4.180
-0.070 (-1.65%)
Aug 29, 2025, 4:00 PM - Market closed

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202005 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2005 - 2019
Non-cash Royalties
100.98M
Log In
Log In
Log In
Log In
Upgrade
Non-cash Royalties Growth
-11.87%
Log In
Log In
Log In
Log In
Upgrade
Clinical Product
482.00K
Log In
Log In
Log In
Log In
Upgrade
Clinical Product Growth
315.52%
Log In
Log In
Log In
Log In
Upgrade
Other
2.00M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-32.74%
Log In
Log In
Log In
Log In
Upgrade
License Fees and Milestones
-
Log In
Log In
Log In
Log In
Upgrade
License Fees and Milestones Growth
-
Log In
Log In
Log In
Log In
Upgrade
Deferred Research and Development
-
Log In
Log In
Log In
Log In
Upgrade
Deferred Research and Development Growth
-
Log In
Log In
Log In
Log In
Upgrade
Research and Development
-
Log In
Log In
Log In
Log In
Upgrade
Research and Development Growth
-
Log In
Log In
Log In
Log In
Upgrade
Royalty Sales Milestone
-
Log In
Log In
Log In
Log In
Upgrade
Deferred Grant
-
Log In
Log In
Log In
Log In
Upgrade
Deferred Grant Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202005 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2005 - 2019
United States
101.46M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-33.83%
Log In
Log In
Log In
Log In
Upgrade
Rest of World
2.00M
Log In
Log In
Log In
Log In
Upgrade
Rest of World Growth
-32.74%
Log In
Log In
Log In
Log In
Upgrade